CBD-Intel – Content types Regulatory briefing

Exit Sessions – could the departure of the AG be good news for cannabis?

Written by Daniel Mollenkamp || 15th November 2018 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

With the ousting of attorney general Jeff Sessions from the Trump administration, members of the US cannabis industry have perked up, hoping the anti-cannabis agenda will exit with him ...

All CBD products for animals will be treated in the UK as medicine

Written by Barnaby Page || 14th November 2018 || Regulatory briefing |

Europe

United Kingdom

Regulation and Legislation

Regulatory briefing

The UK’s Veterinary Medicines Directorate (VMD) has told CBD-Intel that even a product not normally considered a medicine, such as a pet food or livestock feed, will be treated as a pharmaceutical if it contains CBD ...

Michigan says yes, North Dakota says no to recreational cannabis

Written by Daniel Mollenkamp || 7th November 2018 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

Voters in Michigan have voted to legalise the recreational use of cannabis, while those in North Dakota rejected it. In Utah and Missouri medical cannabis use was approved on the day the US turned out to vote in...

Cannabis in the UK now medically legal – up to a point

Written by Freddie Dawson || 1st November 2018 || Regulatory briefing |

Europe

United Kingdom

Regulation and Legislation

Regulatory briefing

Medical cannabis products are now legal in the UK – in very limited circumstances. This could include products without marketing authorisation, if approved by a registered specialist in certain conditions ...

Trade body founder quits, alleging CBD companies have been misled

Written by Freddie Dawson || 31st October 2018 || Regulatory briefing |

Europe

United Kingdom

Policy and Politics

Regulation and Legislation

Regulatory briefing

A founder of the UK Cannabis Trades Association (CTA) has resigned, alleging the industry body has been misleading companies about its role in regulation ...

Canada learning early lessons in enforcement after legalisation

Written by Freddie Dawson || 26th October 2018 || Regulatory briefing |

Canada

North America

Regulatory briefing

The legalisation of Cannabis farming and commercialisation that became effective last week has created a new dynamic legal market for high- and low-THC cannabis strains and by-products in Canada, such as food products or e-liquids. One week after the...

FDA will pass on comments about CBD to WHO drug dependency experts

Written by Freddie Dawson || 22nd October 2018 || Regulatory briefing |

North America

United States

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

Comments invited by the FDA on the potential abuse and medical usefulness of CBD and other cannabis-derived substances will be submitted to the World Health Organization (WHO) ...

Spanish specialists call for clear regulation and an end to CBD seizures

Written by David Palacios || 18th October 2018 || Regulatory briefing |

Europe

Spain

Policy and Politics

Regulation and Legislation

Regulatory briefing

The Spanish Observatory of Medicinal Cannabis has called on the government to stop seizures of CBD oil in Spain, and demanded clear regulation of cannabis-based products ...

CBD prescriptions may be just around the corner for UK patients

Written by CBD-Intel || 16th October 2018 || Regulatory briefing |

Europe

United Kingdom

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

CBD products could be prescribed to British patients from as early as next month after the UK government announced plans to lift restrictions on the medical use of cannabis ...

CBD sellers openly flouting Malta’s prescription-only rule

Written by CBD-Intel || 10th October 2018 || Regulatory briefing |

Europe

Malta

Regulation and Legislation

Regulatory briefing

Though cannabis was legalised for medical use earlier this year, the legal status of CBD in Malta remains uncertain – but shops are ignoring the law that says it should be available only on prescription ...

Private cannabis use legalised – but CBD has a way to go in South Africa

Written by CBD-Intel || 10th October 2018 || Regulatory briefing |

Africa

South Africa

Policy and Politics

Regulation and Legislation

Regulatory briefing

A recent judgement by the Constitutional Court of South Africa which legalised the personal use of cannabis in private may not have a big impact on the CBD market in the country ...

Hemp still on federal narcotics list as Congressional deadline lapses

Written by Daniel Mollenkamp || 8th October 2018 || Regulatory briefing |

North America

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

A deadline for the federal legislature to pass a bill expected to remove hemp and low-THC cannabis from the federal list of narcotics lapsed on 30th September, leaving US hemp farmers in regulatory uncertainty ...

CBD medicines for animals will need UK government approval

Written by Barnaby Page || 26th September 2018 || Regulatory briefing |

Europe

United Kingdom

Regulation and Legislation

Regulatory briefing

CBD-based medical treatments for animals will need government approval before being sold in the UK, after the country’s Veterinary Medicines Directorate (VMD) decided they fall under the definition of veterinary medicines ...

CBD sellers ordered to stop – in states where it’s meant to be legal

Written by Freddie Dawson || 5th September 2018 || Regulatory briefing |

Alabama

Iowa

North America

Ohio

United States

Regulation and Legislation

Regulatory briefing

Although all three states have laws permitting CBD sales, retailers in Ohio, Iowa and Alabama have been told they are breaking the law and ordered to stop ...

WHO’s experts decide CBD should not be controlled as a drug

Written by Freddie Dawson || 23rd August 2018 || Regulatory briefing |

World

Policy and Politics

Regulation and Legislation

Regulatory briefing

CBD should not be scheduled within international drug control conventions, according to the latest meeting of the World Health Organization’s Expert Committee on Drug Dependence ...

Experiments on mice suggest you can’t get addicted to CBD

Written by Marc Beishon || 23rd August 2018 || Regulatory briefing |

Europe

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

A new series of animal studies purports to show that CBD is non-addictive – potentially clearing the way for further research into the mechanisms behind its possible beneficial qualities ...

French warnings over ‘stores likely to be selling illegal products’

Written by David Palacios || 17th August 2018 || Regulatory briefing |

Europe

France

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

Judicial bodies in France have issued statements clarifying the national legal framework for products containing cannabidiol (CBD) and asked local enforcement authorities to ensure compliance with current legislation ...

Fear, hope and anger on the front line of the French CBD revolution

Written by CBD-Intel || 16th August 2018 || Regulatory briefing |

Europe

France

Policy and Politics

Regulation and Legislation

Regulatory briefing

CBD-Intel drops in on a heated meeting of French CBD entrepreneurs, under growing pressure from a government apparently committed to throttling a young industry at birth ...

Confusion reigns in France, under a hostile and muddled government

Written by CBD-Intel || 14th August 2018 || Regulatory briefing |

Europe

France

Regulation and Legislation

Regulatory briefing

Regulation of CBD in France remains unclear, with a variety of potentially conflicting rulings leading to confusion and French companies being discouraged from entering a new and beleaguered market ...

Japan embraces CBD – with eager endorsement in high places

Written by CBD-Intel || 1st August 2018 || Regulatory briefing |

Asia

Japan

Regulation and Legislation

Regulatory briefing

Japan, although a socially conservative nation with stringent laws on both medical and recreational marijuana, now allows the sale of CBD products – and even the prime minister’s wife approves ...

Potentially deadly rat poison found in synthetic cannabinoids, says FDA

Written by Daniel Mollenkamp || 30th July 2018 || Regulatory briefing |

North America

United States

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

Synthetic cannabinoid products being sold in convenience stores and gas stations across the US are contaminated with an ingredient commonly found in rat poison, the US FDA says ...

France adopts zero tolerance approach to THC in vaping products

Written by CBD-Intel || 14th June 2018 || Regulatory briefing |

Europe

France

Regulation and Legislation

Regulatory briefing

The French government has moved to clear up a previous grey area in the regulation of CBD-containing e-liquids, stating that no trace of THC will be allowed in any product for sale ...

US authorities call into question the legality of CBD

Written by CBD-Intel || 8th June 2018 || Regulatory briefing |

North America

United States

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

US government agencies have questioned the legality of cannabidiol (CBD) – just as the industry is starting to benefit from increased public awareness ...

Greece makes it clear – no CBD or shake and vape allowed

Written by CBD-Intel || 8th June 2018 || Regulatory briefing |

Europe

Greece

Regulation and Legislation

Regulatory briefing

The Greek Ministry of Health has issued two circulars on e-cig regulation, clearing up a legal grey area by insisting that both CBD and shake-and-vape products are banned in the country ...

If FDA approves CBD drug it could be a game-changer for the vapour industry

Written by Daniel Mollenkamp || 31st May 2018 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

The first ever FDA-approved cannabis-derived product came a step nearer reality when an independent panel at the agency recommended it as a “safe” and “efficacious” treatment for childhood seizures ...

Italian enforcers issue stern ‘reminder’ – including CBD ban

Written by pablo@ecigintelligence.com || 18th May 2018 || Regulatory briefing |

Europe

Italy

Regulation and Legislation

Regulatory briefing

The Italian Customs and Monopolies Agency (AAMS) has issued a bulletin informing the country’s e-cigarette industry of its interpretation of legal requirements arising from the EU Tobacco Products Directive (TPD) ...

No short-fill shortfall – agency takes on added staff to handle notifications

Written by Freddie Dawson || 18th April 2018 || Regulatory briefing |

Europe

United Kingdom

Regulation and Legislation

Regulatory briefing

So-called “short-fill” products have not affected the number of nicotine-containing e-liquids being notified in the UK, according to an expert from the agency in charge ...

Skip links

Written by Daniel Mollenkamp || 15th November 2018 || Regulatory briefing |

Written by Barnaby Page || 14th November 2018 || Regulatory briefing |

Written by Daniel Mollenkamp || 7th November 2018 || Regulatory briefing |

Written by Freddie Dawson || 1st November 2018 || Regulatory briefing |

Written by Freddie Dawson || 31st October 2018 || Regulatory briefing |

Written by Freddie Dawson || 26th October 2018 || Regulatory briefing |

Written by Freddie Dawson || 22nd October 2018 || Regulatory briefing |

Written by David Palacios || 18th October 2018 || Regulatory briefing |

Written by CBD-Intel || 16th October 2018 || Regulatory briefing |

Written by CBD-Intel || 10th October 2018 || Regulatory briefing |

Written by CBD-Intel || 10th October 2018 || Regulatory briefing |

Written by Daniel Mollenkamp || 8th October 2018 || Regulatory briefing |

Written by Barnaby Page || 26th September 2018 || Regulatory briefing |

Written by Freddie Dawson || 5th September 2018 || Regulatory briefing |

Written by Freddie Dawson || 23rd August 2018 || Regulatory briefing |

Written by Marc Beishon || 23rd August 2018 || Regulatory briefing |

Written by David Palacios || 17th August 2018 || Regulatory briefing |

Written by CBD-Intel || 16th August 2018 || Regulatory briefing |

Written by CBD-Intel || 14th August 2018 || Regulatory briefing |

Written by CBD-Intel || 1st August 2018 || Regulatory briefing |

Written by Daniel Mollenkamp || 30th July 2018 || Regulatory briefing |

Written by CBD-Intel || 14th June 2018 || Regulatory briefing |

Written by CBD-Intel || 8th June 2018 || Regulatory briefing |

Written by CBD-Intel || 8th June 2018 || Regulatory briefing |

Written by Daniel Mollenkamp || 31st May 2018 || Regulatory briefing |

Written by pablo@ecigintelligence.com || 18th May 2018 || Regulatory briefing |

Written by Freddie Dawson || 18th April 2018 || Regulatory briefing |

Sign up to our newsletter

Subscribe for the latest industry updates

Footer

Don't miss out